BusinessBioNews Services Puts Sharp Focus on Rare Disease Day 2018By Nasdaq OMXFeb 28, 2018, 1:45 PM UTC
BusinessAFA: Signing of New RAISE Family Caregiver Law Positive Step, But Continued Action Needed from WashingtonBy Nasdaq OMXJan 23, 2018, 2:50 PM UTC
BusinessCURE Pharmaceutical Subsidiary, Oak Therapeutics, Completes Critical Milestone in Phase 1 of NIH Grant to Develop Oral Dissolvable Strip for TuberculosisBy Nasdaq OMXAug 22, 2017, 3:19 PM UTC
BusinessCrinetics Pharmaceuticals Awarded $2.8 Million SBIR Grant to Support Development of Acromegaly Drug Candidate CRN00808By Nasdaq OMXJul 13, 2017, 5:00 PM UTC
BusinessTrevena Attends National Institutes of Health Meeting to Discuss Development of Novel, Improved Pain MedicationsBy Nasdaq OMXJun 20, 2017, 8:01 PM UTC
BusinessRheumatology Leaders Oppose Sweeping Healthcare Cuts in Trump Administration BudgetBy Nasdaq OMXMay 23, 2017, 8:52 PM UTC
BusinessRheumatology Leaders Oppose Sweeping Healthcare Cuts in Trump Administration BudgetBy Nasdaq OMXMay 23, 2017, 8:52 PM UTC
BusinessAlzheimer’s Foundation of America’s Statement on the Trump Administration’s Proposed 2018 BudgetBy Nasdaq OMXMay 23, 2017, 7:41 PM UTC
